Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. classification

Annals of Oncology

Volumn 8, Issue 6, 1997, Pages 583-592

  Ascani, S ^a   Zinzani, P L ^a   Gherlinzoni, F ^a   Sabattini, E ^a   Briskomatis, A ^a   De Vivo, A ^a   Piccioli, M ^a   Fraternali Orcioni, G ^a   Pieri, F ^a   Goldoni, A ^a   Piccaluga, P P ^a   Zallocco, D ^a   Burnelli, R ^a   Leoncini, L ^b   Falini, B ^c   Tura, S ^a   Pileri, S A ^a,d  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Anaplastic large cell lymphoma; Classification; Clinics; Histology; Immunohistochemistry; Peripheral T cell lymphoma

Indexed keywords

ADOLESCENT; ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; CANCER CLASSIFICATION; CANCER SURVIVAL; CHILD; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; T CELL LYMPHOMA;

EID: 8544264540     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008200307625     Document Type: Article

References (59)

1. Takatsuki K, UchiyamaT, Sagawa K et al. Adult T-cell leukemia in Japan. Excerpta Medica Int Congr Ser 1976; 415: 73-7.
2. Uchiyama T, Yodoi J, Sagawa K et al. Adult T-cell leukemia: Clinical and hematologic features of 17 cases. Blood 1977; 50: 481 92.
3. Swerdlow SH, Habeshaw JA, Rohatiner AZS et al. Caribbean T-cell lymphoma/leukemia. Cancer 1984; 54: 687-96.
4. Suchi T, Lennert K, Tu L-Y et al. Histopathology and immunohistochemistry of peripheral T-cell lymphomas: A proposal for their classification. J Clin Pathol 1987; 40: 995-1015.
5. Stansfeld A, Diebold J, Kapanci Y et al. Updated Kiel Classification for lymphomas. Lancet 1988; I: 292-3.
6. Su I-J, Wang C-H, Cheng A-L et al. Characterization of the spectrum of postthymic T-cell malignancies in Taiwan. A clinicopathologic study of HTLV1-positive and HTLV1-negative cases. Cancer 1988; 61: 2060-70.
7. Nakamura S, Suchi T. A clinicopathologic study of node-based, low-grade, peripheral T-cell lymphoma. Angioimmunoblastic lymphoma. T-zone lymphoma. and lymphoepithelioid lymphoma. Cancer 1991; 67: 2565-78.
8. Shimoyama M, and Members of the Lymphoma Study Group (1984-87). Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. Br J Haematol 1991; 79: 428-37.
9. Lennert K, Feller AC. Histopathology of non-Hodgkin's Lymphomas (Based on the Updated Kiel Classification). Berlin: Springer-Verlag 1992.
10. Takagi N, Nakamura S, Ueda R et al. A phenotypic and genotypic study of three node-based, low-grade peripheral T-cell lymphomas: Angioimmunoblastic lymphoma, T-zone lymphoma, and lymphoepithelioid lymphoma. Cancer 1992; 69: 2571-82.
11. Nakamura S, Koshikaua T, Koike K et al. Phenotypic analysis of peripheral T-cell lymphoma among the Japanese. Acta Pathol Jpn 1993; 43: 396-412.
12. Nakamura S, Suchi T, Koshikaua T et al. Clinicopathologic study of 212 cases of peripheral T-cell lymphoma among the Japanese. Cancer 1993; 72: 1762-72.
13. Zhou XG, Hamilton-Dutoit SJ, Yan QH et al. High frequency of Epstein-Barr virus in Chinese peripheral T-cell lymphoma. Histopathol 1994; 24: 115-22.
14. Khan G, Norton AJ, Slavin G. Epstein-Barr virus in angioimmunoblastic T-cell lymphoma. Histopathol 1993; 22: 145-9.
15. Weiss LM, Crabtree GS, Rouse RV et al. Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas. Am J Pathol 1985; 118: 316-24.
16. Weisenburger DD, Astorino RN, Glassey FJ et al. Peripheral T-cell lymphoma. A clinicopathologic study of a morphologically diverse entity. Cancer 1985; 52: 2061-8.
17. Ramsay AD, Smith WJ, Earl HM et al. T-cell lymphomas in adults: A clinicopathological study of eighteen cases. J Pathol 1987; 152: 63-76.
18. GisselbrechtC, Gaulard Ph, Lepage E et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphoma. Blood 1996; 88 (Suppl 1): 1159.
19. Armitage JO, Greer JP, Levine AM et al. Peripheral T-cell lymphoma. Cancer 1989; 63: 158-63.
20. Coiffier B, Brousse N, Peuchmaur M et al. Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: A prospective study of 361 immunophenotyped patients treated with LNH-84 regimen. Ann Oncol 1990; 1: 45 50.
21. Pinkus GS, O'Hara C, Said JW. Peripheral/post-thymic T-cell lymphomas: A spectrum of disease. Clinical, pathologic and immunologic features of 78 case. Cancer 1990; 65: 971-98.
22. Chott A, Augustin I, Wrba F et al. Peripheral T-cell lymphomas: A clinicopathologic study of 75 cases. Hum Pathol 1990; 21: 1117-25.
23. Haioun C, Gaulard P, Bourquelot Pet al. Clinical and biological analysis of peripheral T-cell lymphomas: A single-institution study. Leuk Lymph 1992; 7: 449-55.
24. Montalban C, Obeso G, Gallego A et al. Peripheral T-cell lymphoma: a Clinicopathological study of 41 cases and evaluation of the prognostic significance of the updated Kiel classification. Histopathol 1993; 22: 303-10.
25. Winberg CD. Peripheral T-cell lymphoma: Morphologic and immunologic observations. Am J Clin Pathol 1993; 99: 426-35.
26. Grogan TM, Fielder K, Rangel C et al. Peripheral T-cell lymphoma: Aggressive disease with heterogeneous immunotypes. Am J Clin Pathol 1985; 83: 279-88.
27. Hastrup N, Ralfkiaer E, Pallesen G. Aberrant phenotypes in peripheral T-cell lymphomas. J Clin Pathol 1989; 42: 398-402.
28. Cabecadas JM, Isaacson PG. Phenotyping of T-cell lymphomas in paraffin sections - which antibodies? Histopathology 1991; 19: 419 24.
29. Wood KM, Pallesen G, Ralfkiaer E et al. Heterogeneity of CD3 antigen expression in T-cell lymphoma. Histopathol 1993; 22: 311-7.
30. Chadburn A, Knowles DM. Paraffin-resistant antigens detectable by antobodies L26 and polyclonal CD3 predict the B- or T-cell lineage of 95% of diffuse aggressive non-Hodgkin's lymphomas. Am J Clin Pathol 1994; 102: 284-91.
31. Lippman SM, Miller TP, Spier CM et al. The prognostic significance of the immunotype in diffuse large-cell lymphoma: A comparative study of the T-cell and B-cell phenotype. Blood 1988; 72: 436-41.
32. Armitage JO, Vose JM, Linder J et al. Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma. J Clin Oncol 1989; 7: 1783-7.
33. Kwak LW, Wilson M, Weiss LM et al. Similar outcome of treatment of B-cell and T-cell diffuse large cell lymphomas: The Stanford experience. J Clin Oncol 1991; 9: 1426-30.
34. Rosenberg SA. Classification of lymphoid neoplasms. Blood 1994; 84: 1359-60.
35. Non-Hodgkin's lymphoma pathologic classification project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a Working Formulation for clinical usage. Cancer 1982; 49: 2112 35.
36. Noorduyn LA, van der Valk P, van Heerde P et al. Stage is a better prognostic indicator than morphologic subtype in primary non cutaneous T-cell lymphoma. Am J Clin Pathol 1990; 93: 49-57.
37. Hastrup N, Hamilton-Dutoit S, Ralfkiaer E et al. Peripheral T-cell lymphomas: An evaluation of reproducibility of the updated Kiel classification. Histopathology 1991; 18: 99-105.
38. Su I-J, Hsieh H-C, Lin K-H et al. Aggressive peripheral T-cell lymphomas contain Epstein-Barr viral DNA: A clinicopathologic and molecular analysis. Blood 1991; 77: 799-808.
39. Harris N, Jaffe E, Stein H et al. A Revised European-American Classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361 92.
40. Fisher RI, Gaynor ER, Dahlberg S et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 1993; 328: 1002-6.
41. Pileri S, Bocchia M, Baroni CD et al. Anaplastic large cell lymphoma (CD30+/KI-1+): Results of the prospective clinicopathologic study of 69 cases. Br J Haematol 1994; 86: 513 23.
42. Zinzani PL, Pileri S, Martelli M et al. Anaplastic large cell lymphoma (Ki-1/CD30+): Clinical and prognostic evaluation of 90 adult patients. J Clin Oncol 1996; 14: 955 62.
43. Cordell JL, Falini B, Erber WN et al. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 32: 219 29.
44. Cattoretti G, Pileri S, Parravicini C et al. Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol 1993; 171: 83-98.
45. Leoncini L, Del Vecchio MT, Megha T et al. Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. Am J Pathol 1993; 142: 755 63.
46. Gerdes J, Stein H, Pileri S et al. Prognostic relevance of tumour-cell growth fraction in malignant non-Hodgkin's lymphomas. Lancet 1987; ii: 448-9.
47. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. JAMA 1958; 53: 457 81.
48. Cox DR. Analysis of binary data. London: Methuen 1970.
49. Cox DR. Regression models and life tables (with discussion). J R Slat Soc B 1972; 34: 187 220.
50. Falini B, Pileri S, De Solas I et al. Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood 1990; 75: 434-44.
51. The International non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphomas. N Engl J Med 1993; 329: 987 94.
52. Pileri S, Falini B, Stein H et al. Lymphohistiocytic T-cell lymphoma. Anaplastic large cell lymphoma (CD30+/Ki-1+) with a high content of reactive histiocyles. A clinical, pathological and immunohistological study of 13 cases. Histopathology 1990; 16: 383-91.
53. Vecchi V, Burnelli R, Pileri S et al. Anaplastic large cell lymphoma (Ki-I+/CD30+) in childhood. Med Pedialr Oncol 1993; 21: 402-10.
54. Massimino M, Gasparini M, Giardini R. Ki-1 (CD30) anaplastic large-cell lymphoma in children. Ann Oncol 1995; 6: 915 20.
55. Shiota M, Nakamura S, Ichinohasama R et al. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ ALK: A distinct clinicopathologic entity. Blood 1995; 86: 1954-60.
56. Herbst H, Anagnostopoulos J, Hienze B et al. ALK gene products in anaplastic large cell lymphomas and Hodgkin's disease. Blood 1995; 86: 1694-700.
57. Siegert W, Nerl C, Agthe A et al. Angioimmunoblastic lymphoadenopathy (AILD)-type T-cell lymphoma: Prognostic impact of clinical observations and laboratory findings at presentation. Ann Oncol 1995; 6: 659-64.
58. Falini B, Pileri S, Pizzolo G et al. CD30 (Ki-1) molecule: A new cylokine receptor of the tumor necrosis factor receptor super-family as a tool for diagnosis and immunotherapy. Blood 1995; 85: 1 14.
59. Leung Cy, Ho FCS, Srivastava G et al. Usefulness of follicular dendritic cell pattern in classification of peripheral T-cell lymphomas. Histopathology 1993; 23: 433-7.